WO2024013586 - INJECTABLE HERBAL OINTMENT FOR THE TREATMENT OF SUBCLINICAL MASTITIS: COMBINING SPIRULINA ALGAE EXTRACT AND MANGROVE LEAF EXTRACT

National phase entry is expected:
Publication Number WO/2024/013586
Publication Date 18.01.2024
International Application No. PCT/IB2023/056329
International Filing Date 19.06.2023
Title **
[English] INJECTABLE HERBAL OINTMENT FOR THE TREATMENT OF SUBCLINICAL MASTITIS: COMBINING SPIRULINA ALGAE EXTRACT AND MANGROVE LEAF EXTRACT
[French] ONGUENT À BASE D'HERBES INJECTABLE POUR LE TRAITEMENT DE LA MAMMITE SOUS-CLINIQUE : COMBINAISON D'EXTRAIT D'ALGUE SPIRULINE ET D'EXTRAIT DE FEUILLE DE PALÉTUVIER
Applicants **
SHIRANI, Sadaf
GHAVAM MOSTAFAVI, Pargol
MASHINCHIAN MORADI, Ali
Inventors
ATTARI, Rezvan
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1901
EPO Filing, Examination, Granting8468
Japan Filing, Examination, Granting2097
South Korea Filing, Examination, Granting1759
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 18,965

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] the process for preparing an injectable herbal ointment for the treatment of subclinical mastitis, comprising: Combining 300 mg of ethanolic extract of spirulina algae (Platensis Spirulina) and 90 mg of ethanolic extract of mangrove leaves (Avicennia marina) in each 10 ml tube of the ointment and adding 10 ml of sanitary liquid paraffin as a carrier. the extraction process is carried out using the ethanol method with a 10% mass-volume immersion technique. the extracts are sterilized using a 0.22-micron microbial filter. The ointment is supplied as an intramammary ointment for the treatment of subclinical mastitis.[French] L'invention concerne un procédé de préparation d'un onguent à base d'herbes injectable pour le traitement de la mammite sous-clinique, comprenant : la combinaison de 300 mg d'extrait éthanolique d'algue spiruline (Platensis Spirulina) et de 90 mg d'extrait éthanolique de feuilles de palétuvier (Avicennia marina) dans chaque tube de 10 ml de l'onguent et l'ajout de 10 ml de paraffine liquide sanitaire en tant que véhicule. Le procédé d'extraction est mis en œuvre à l'aide du procédé à l'éthanol avec une technique d'immersion à 10 % en volume en masse. Les extraits sont stérilisés à l'aide d'un filtre antimicrobien de 0,22 micron. L'onguent est fourni sous la forme d'un onguent intramammaire pour le traitement de la mammite sous-clinique.